ArriVent
ArriVent BioPharma
AVBP biotech USA
Quick answer
ArriVent is a biotech company (AVBP) headquartered in NEWTOWN SQUARE, PA, USA with 5 tracked pipeline programs.
Pipeline (5)
project
Firmonertinib
Non-Small-Cell Lung Cancer
1 trials projectFirmonertinib
NSCLC
1 trials projectfurmonertinib 240 mg oral, daily
Metastatic Non-Small Cell Lung Cancer
1 trials projectFurmonertinib
Non-Small Cell Lung Cancer (NSCLC)
1 trials projectMRG007
Locally Advanced or Metastatic Solid Tumors
1 trials